P1.02 * MesomiR 1: A Phase I study of TargomiRs in patients with refractory malignant pleural mesothelioma (MPM) and lung cancer (NSCLC)
van Zandwijk, N., Pavlakis, N., Kao, S., Clarke, S., Lee, A., Brahmbhatt, H., Macdiarmid, J., Pattison, S., Leslie, F., Huynh, Y., Linton, A., Reid, G.Volume:
26
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv090.2
Date:
March, 2015
File:
PDF, 34 KB
2015